Investor · Durham, CT

Stephen Strittmatter

Open Stephen in the network graph →

Filings

8

SEC Form D

Connections

62

co-filers

Capital

$9.9M

across filings

Active

Jun 2020

to May 2025

Most-connected co-filers (62)

Robert A. Bettigole · New Haven, CT5 shared Stephen Bloch · MORRISVILLE, NC5 shared Gregory P. Ho · New York, NY3 shared Timothy P. Siegert · Hamden, CT3 shared Paul C. Fonteyne · Cambridge, MA3 shared Adrian Martin-Jimenez · New York, NY2 shared Kimberly D. Stephens · HALIFAX, Nova Scotia, Canada2 shared Steve B. Sershen · Chester, SD2 shared Juergen C. Froehlich · HALIFAX, Nova Scotia, Canada2 shared Theresa C. Matkovits · HALIFAX, Nova Scotia, Canada2 shared Michael Quinlivan · London, United Kingdom2 shared Armand C. Balboni · HALIFAX, Nova Scotia, Canada2 shared Katherine Wood · Fort Worth, TX2 shared Todd G. Sisitsky · Fort Worth, TX2 shared Edward Patton · Needham, MA2 shared Robert N. Nix, Iii · Philadelphia, PA2 shared Charles B. Crawford, Jr · Philadelphia, PA2 shared Daniel Conant · Shepherdstown, WV2 shared Louis J. Decesare, Jr · Philadelphia, PA2 shared Paul D. Rutkowski · Philadelphia, PA2 shared Jill K. Jinks · Philadelphia, PA2 shared Christopher Trosper · West Des Moines, IA2 shared Warren A. Kirshenbaum · Newton, MA2 shared Joseph Bramante · Houston, TX2 shared

Recent filings (8)

Allyx Therapeutics, Inc.Mar 2026 · 6 co-filers$4.0M TPG Private Equity Opportunities, L.P.May 2025 · 26 co-filers Allyx Therapeutics, Inc.Feb 2023 · 17 co-filers$2.3M Appili Therapeutics Inc.Sep 2021 · 19 co-filers$3.5M Allyx Therapeutics, Inc.Jun 2021 · 17 co-filers$8.0M Cannes Holding Parent, Inc.Jun 2020 · 11 co-filers Appili Therapeutics Inc.Jun 2020 · 17 co-filers$1.0M Axerion Therapeutics, Inc.Apr 2010 · 7 co-filers$758K

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Stephen in the interactive graph →